PlasmaTech Biopharmaceuticals closes underwritten public offering of common … – News-Medical.net
PlasmaTech Biopharmaceuticals closes underwritten public offering of common …News-Medical.netPlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase …PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingCNNMoney all 3 news articles …read more